Learn more

TIGENIX NV

Overview
  • Total Patents
    60
  • GoodIP Patent Rank
    211,120
About

TIGENIX NV has a total of 60 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ROYAL COLLEGE SURGEONS IRELAND, JOHNS HOPKINS SINGAPORE PTE LT and NEOSTEM INC.

Patent filings per year

Chart showing TIGENIX NVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Luyten Frank 34
#2 De Bari Cosimo 26
#3 Dell Accio Francesco 25
#4 Muir-Mcleod Paula 9
#5 Knipper Andreas 9
#6 Bari Cosimo De 7
#7 Accio Francesco Dell 5
#8 Dell'Accio Francesco 3
#9 Motmans Kris 2
#10 Kris Motmans 2

Latest patents

Publication Filing date Title
WO2010092100A1 Biopsy device
GB0904411D0 Biopsy device
GB0902495D0 Biopsy device
US2010068715A1 Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production
NZ589814A Methods to maintain, improve and restore the cartilage phenotype of chondrocytes
EP1653994A2 Use of cxcl6 chemokine in the prevention or repair of cartilage defects
AU2003266282A1 Compositions comprising muscle progenitor cells and uses thereof
US7482114B2 In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation
AU2002308249A1 Polynucleotide sequences and vectors useful for the prevention or treatment of bone- or cartilage-related disorders
EP1282690A1 Isolation of precursor cells and their use for tissue repair
WO0124833A2 In vivo assay for testing the phenotypic stability